- Home
- UUU vs PHIO Comparison
UUU vs PHIO Comparison
Compare UUU & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUU
- PHIO
- Stock Information
- Founded
- UUU 1969
- PHIO 2011
- Country
- UUU United States
- PHIO United States
- Employees
- UUU N/A
- PHIO N/A
- Industry
- UUU Electronic Components
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- UUU Technology
- PHIO Health Care
- Exchange
- UUU Nasdaq
- PHIO Nasdaq
- Market Cap
- UUU 12.6M
- PHIO 12.1M
- IPO Year
- UUU N/A
- PHIO N/A
- Fundamental
- Price
- UUU $4.38
- PHIO $1.47
- Analyst Decision
- UUU
- PHIO Strong Buy
- Analyst Count
- UUU 0
- PHIO 3
- Target Price
- UUU N/A
- PHIO $10.67
- AVG Volume (30 Days)
- UUU 111.7K
- PHIO 8.4M
- Earning Date
- UUU 11-19-2025
- PHIO 11-11-2025
- Dividend Yield
- UUU 22.42%
- PHIO N/A
- EPS Growth
- UUU N/A
- PHIO N/A
- EPS
- UUU 1.19
- PHIO N/A
- Revenue
- UUU $22,789,285.00
- PHIO N/A
- Revenue This Year
- UUU N/A
- PHIO N/A
- Revenue Next Year
- UUU N/A
- PHIO N/A
- P/E Ratio
- UUU $3.96
- PHIO N/A
- Revenue Growth
- UUU 30.84
- PHIO N/A
- 52 Week Low
- UUU $1.65
- PHIO $0.97
- 52 Week High
- UUU $8.27
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- UUU 43.68
- PHIO 18.76
- Support Level
- UUU $4.30
- PHIO $2.08
- Resistance Level
- UUU $4.80
- PHIO $4.19
- Average True Range (ATR)
- UUU 0.50
- PHIO 0.27
- MACD
- UUU -0.08
- PHIO -0.07
- Stochastic Oscillator
- UUU 4.79
- PHIO 0.55
About UUU Universal Security Instruments Inc.
Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.